Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 8, 2016 - Issue
Submit an article Journal homepage
386
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Jeffrey D Miller1 Truven Health Analytics Inc, Cambridge, MA, USACorrespondence[email protected]
,
Xin Ye2 Daiichi Sankyo Inc, Parsippany, NJ, USA
,
Gregory M Lenhart1 Truven Health Analytics Inc, Cambridge, MA, USA
,
Amanda M Farr1 Truven Health Analytics Inc, Cambridge, MA, USA
,
Oth V Tran1 Truven Health Analytics Inc, Cambridge, MA, USA
,
W Jackie Kwong2 Daiichi Sankyo Inc, Parsippany, NJ, USA
,
Elizabeth A Magnuson3 St Luke Mid-America Heart Institute, Kansas City, MO, USA
&
William S Weintraub4 Center for Heart and Vascular Health, Christiana Care Health System, Newark, DE, USA
 show all
Pages 215-226 | Published online: 20 May 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.